17^th European Diabetes and Endocrinology Congress November 20-21, 2023 Dubai, UAE

Track-01: Diabetes

Diabetes is brought about by the lowered creation of insulin or by a lowered capacity to use insulin. Insulin, the hormone delivered by the beta cells in the pancreas, permits (glucose) cells to have the capacity to use glucose. This hormone is abecedarian for glucose to go from the blood to within the body cells. With deficient insulin, glucose develops in the circulatory system as opposed to going into the cells. The body can not use glucose for vitality in malignancy of the elevated quantities of glucose in the circulatory system. This causes unreasonable thirst, pee, and appetite, which are the most extensively honored side goods of diabetes. The cornucopia of sugar stays in the blood and is also vacated by the feathers. This sickness happens in a many structures, yet the most well- known are Type I Diabetes or Juvenile Onset Diabetes or Insulin-Dependent Diabetes Mellitus (IDDM), Type II orNon-Insulin Dependent Diabetes Mellitus (NIDDM), and Gestational. 

Diabetes Conference | Diabetes Conferences | Diabetes congress | Endocrinology Conference | Obesity Conference | Euro Endocrinology 2023 | Diabetes Conference 2023 | Diabetes Conferences | Diabetes congress 2023 | Endocrine Disorders | Diabetes Congress | Type1 Diabetes | Type2 Diabetes  | Euro Endocrinology 2023 | Diabetes mellitus | Diabetes Treatment

Track-02: Endocrinology

Endocrinology is a branch of biology and drug dealing with the endocrine system, the endocrine system is a network of glands that produce and release hormones. These hormones are in charge of several functions in the body, from heartbeat to tissue growth to the creation of new life. These glands that produce and release hormones that help control numerous important body functions, including the body's capability to change calories into energy that powers cells and organs. The endocrine system influences how your heart beats, how your bones and apkins grow, indeed your capability to make a baby. It plays a vital part in whether or not you develop diabetes, thyroid complaint, growth diseases, sexual dysfunction, and a host of other hormone- related diseases.

Diabetes Conference | Diabetes Conferences | Diabetes congress | Endocrinology Conference | Obesity Conference | Euro Endocrinology 2023 | Diabetes Conference 2023 | Diabetes Conferences | Diabetes congress 2023 | Endocrine Disorders | Diabetes Congress | Type1 Diabetes | Type2 Diabetes  | Euro Endocrinology 2023 | Diabetes mellitus | Diabetes Treatment

Track-03: Diabetes mellitus type 1 

Diabetes mellitus type 1 ( else called type 1 diabetes) is a type of diabetes mellitus that issues from the vulnerable system obliteration of the insulin- delivering beta cells in the pancreas. The preceding absence of insulin prompts overinflated glucose within the blood and pee. The established instantiations square measure regular pee, overinflated thirst, overinflated pining, and weight reduction. The reason for DM type one is obscure. Type one diabetes are frequently honored from type two from antibody testing. The C-peptide test, which measures endogenous insulin generation, will likewise be utilised. Organization of insulin is abecedarian for survival. Insulin treatment must be progressed with uncertainly and generally doesn't disable ordinary every day exercises. Individualities square measure unremarkably ready to freely deal with their diabetes; Be that because it might, for a many this will challenge. Undressed, diabetes can bring about multitudinous confusions. Violent confusions incorporate diabetic acidosis and nonketotic hyperosmolar reverie like state. Genuine long run complications known with high glucose incorporate coronary sickness, stroke, order disappointment, bottom ulcers and damage to the eyes.

Diabetes Conference | Diabetes Conferences | Diabetes congress | Endocrinology Conference | Obesity Conference | Euro Endocrinology 2023 | Diabetes Conference 2023 | Diabetes Conferences | Diabetes congress 2023 | Endocrine Disorders | Diabetes Congress | Type1 Diabetes | Type2 Diabetes  | Euro Endocrinology 2023 | Diabetes mellitus | Diabetes Treatment

Track-04: Pediatric Endocrinology

Pediatric endocrinology is a remedial subspecialty managing couples of the endocrine organs, for example, kinds of physical development and sexual advancement in adolescence, diabetes, and some further. By age, pediatric endocrinologists, contingent on the age range of the cases they treat, tend to cases from the outset to late youth and immature majority. By illness, the most extensively honored sickness of the speciality is sort Type1 diabetes, which more frequently than not represents no lower than half of a regular clinical practice. The following most normal issue is development issues, particularly those manageable to development hormone treatment. Pediatric endocrinologists are generally the essential doctors needed in the remedial consideration of babies and kiddies with intersex issues. The claim to fame also manages hypoglycaemia and different types of hyperglycaemia in adolescence, kinds of pubescence, too another adrenal, thyroid, and pituitary issues. Multitudinous pediatric endocrinologists have interests and chops in the bone digestion system, lipid digestion system, immature gynecology, or natural blunders of the digestion system.

Diabetes Conference | Diabetes Conferences | Diabetes congress | Endocrinology Conference | Obesity Conference | Euro Endocrinology 2023 | Diabetes Conference 2023 | Diabetes Conferences | Diabetes congress 2023 | Endocrine Disorders | Diabetes Congress | Type1 Diabetes | Type2 Diabetes  | Euro Endocrinology 2023 | Diabetes mellitus | Diabetes Treatment

Track-05: Diabetes mellitus type 2

Type 2 diabetes is a long- haul metabolic turmoil that's portrayed by high glucose, insulin resistance, and a relative absence of insulin. Introductory aspect goods incorporate overinflated thirst, incessant pee, and unexplained weight reduction. Suggestions might likewise incorporate overinflated desire, feeling tired, and bruises that do not recoup. Regular suggestions go ahead gradationally. Long haul complications from high glucose incorporate coronary unwellness, strokes, diabetic retinopathy which can bring about visual impairment, order disappointment, and poor bloodstream in the accessories which may prompt disposals. The unexpected onset of hyperosmolar hyperglycaemic state may happen; in any case, ketoacidosis is unknown. Type 2 diabetes is substantially preventable by staying a typical weight, rehearsing constantly, and eating legitimately. Treatment includes exertion and salutary changes. In the event that glucose situations do not feel to be sufficiently brought down, the drug metformin is regularly suggested. Numerous individualities may in the end likewise need insulin infusions. In that on insulin, routinely check glucose situations is encouraged, in any case, this may not be needed in those taking capsules. Bariatric surgery constantly enhances diabetes in individualities who are stout. Rates of type 2 diabetes have expanded uniquely since 1960 in comparable with corpulence.

Diabetes Conference | Diabetes Conferences | Diabetes congress | Endocrinology Conference | Obesity Conference | Euro Endocrinology 2023 | Diabetes Conference 2023 | Diabetes Conferences | Diabetes congress 2023 | Endocrine Disorders | Diabetes Congress | Type1 Diabetes | Type2 Diabetes  | Euro Endocrinology 2023 | Diabetes mellitus | Diabetes Treatment

Track-06: Diabetic Nutrition and Diet

Medical nutrition remedy is an important part of diabetes treatment and self- guidance education. A diabetes diet entails consuming the everyday foods in temperance and clinging to a regular mess schedule. A diabetes diet is a nutritional, low- fat, low-calorie eating plan that's naturally rich in nutrients. Fruits, vegetables, and whole grains are essential factors. In fact, for the vast maturity of people, a diabetes diet is the ideal eating plan. The plan aids with blood sugar (glucose) control, weight operation, and the operation of heart complaint threat factors similar as high blood pressure and high blood fat.

Diabetes Conference | Diabetes Conferences | Diabetes congress | Endocrinology Conference | Obesity Conference | Euro Endocrinology 2023 | Diabetes Conference 2023 | Diabetes Conferences | Diabetes congress 2023 | Endocrine Disorders | Diabetes Congress | Type1 Diabetes | Type2 Diabetes  | Euro Endocrinology 2023 | Diabetes mellitus | Diabetes Treatment

Track-07: Thyroid Disorders

Thyroid issues aren't uncommon in youths, but rather they aren't as regular as guardians. Hyperthyroidism an hyperactive thyroid organ is seen just formerly in a while in babe. This condition is indicated to as neonatal hyperthyroidism. Although thyroid disease happens lower important of the time in kiddies than in grown-ups, the signs and suggestions can be similar. In any case, there are a couple of essential contrasts that should be conveyed to light. Inborn hypothyroidism is a confusion that influences Newborn children during parturition and happens in around 1 in 4000 live-conceived babies. It's portrayed by the loss of thyroid capacity because the thyroid organ neglects to grow regularly. At times, the organ is completely absent. Around 10 of cases are brought on by a catalyst deformity prompting low hormones generation, iodine lack, and a mind pituitary organ variation from the norm. On the off chance that the determination is heldup, and quick treatment isn't given, innate hypothyroidism can prompt development and constructive defects, and serious psychological impediments (cretinism).

Diabetes Conference | Diabetes Conferences | Diabetes congress | Endocrinology Conference | Obesity Conference | Euro Endocrinology 2023 | Diabetes Conference 2023 | Diabetes Conferences | Diabetes congress 2023 | Endocrine Disorders | Diabetes Congress | Type1 Diabetes | Type2 Diabetes  | Euro Endocrinology 2023 | Diabetes mellitus | Diabetes Treatment

Track-08: Advances in Endocrinology Metabolism

Treat patients with hyperparathyroidism, Address particular issues of Graves' disease including thyrocardiac ailment, ophthalmopathy, dermopathy, delayed pregnancy, mammary, Use the 2015 ATA rules in the administration of their patients with thyroid knobs and thyroid malignancy determination, Determine when to do atomic hereditary testing amid assessment of a thyroid knob, Identify the ordinarily experienced adrenal and pituitary issue (clinical cases), Counsel patients on ripeness issues while being dealt with for growth, Provide the best treatment for transgender patients, Use the new lipid bringing operators and how down to oversee quiet who can't take statins. Intrinsic adrenal hyperplasia (CAH) are any of a few autosomal latent sicknesses coming about because of changes of qualities for catalysts intervening the biochemical strides of creation of mineralocorticoids, glucocorticoids or sex steroids from cholesterol by the endocrine organs (steroid beginning).

Diabetes Conference | Diabetes Conferences | Diabetes congress | Endocrinology Conference | Obesity Conference | Euro Endocrinology 2023 | Diabetes Conference 2023 | Diabetes Conferences | Diabetes congress 2023 | Endocrine Disorders | Diabetes Congress | Type1 Diabetes | Type2 Diabetes  | Euro Endocrinology 2023 | Diabetes mellitus | Diabetes Treatment

Track-09: Endocrine Disorders

Endocrine disorders are conditions related to the endocrine glands of the body. The endocrine system is a network of glands that produce and discharge hormones that help control many significant body capacities, including the body's capacity to change calories into vitality that powers cells and organs. The endocrine system impacts how your heart beats, how your bones and tissues develop, indeed your capacity to be born a baby. It assumes an essential job in whether or not you develop diabetes, thyroid illness, development issue, sexual brokenness, and a large group of other hormone- related issues.

Diabetes Conference | Diabetes Conferences | Diabetes congress | Endocrinology Conference | Obesity Conference | Euro Endocrinology 2023 | Diabetes Conference 2023 | Diabetes Conferences | Diabetes congress 2023 | Endocrine Disorders | Diabetes Congress | Type1 Diabetes | Type2 Diabetes  | Euro Endocrinology 2023 | Diabetes mellitus | Diabetes Treatment

Track-10: Diabetes Research in Clinical Practice

Diabetes study and New remedial targets accessible for diabetes incorporates Incretion based treatments, oral helpful drivers like secretagogues, cell recovery and growth and foundational organism treatments. Embryonic uninhabited cell and fetal antecedent cell transplantation treatments are the significant undifferentiated cell treatments accessible for Diabetes. Away from the on high of, fully different procedure methodologies in diabetes administration operation are given as these days that square measure presumptuous an essential half in recognizable evidence of rates bringing about diabetes helping in Early Discovery of Diabetes. These procedures are likewise precious in concentrating on the mixture pathologist of diabetes revealing completely different treatment prospects and model development forms for survival expectation.

Diabetes Conference | Diabetes Conferences | Diabetes congress | Endocrinology Conference | Obesity Conference | Euro Endocrinology 2023 | Diabetes Conference 2023 | Diabetes Conferences | Diabetes congress 2023 | Endocrine Disorders | Diabetes Congress | Type1 Diabetes | Type2 Diabetes  | Euro Endocrinology 2023 | Diabetes mellitus | Diabetes Treatment

Track-11: Metabolism, Endocrinology & Diabetes

Diabetes Conference | Diabetes Conferences | Diabetes congress | Endocrinology Conference | Obesity Conference | Euro Endocrinology 2023 | Diabetes Conference 2023 | Diabetes Conferences | Diabetes congress 2023 | Endocrine Disorders | Diabetes Congress | Type1 Diabetes | Type2 Diabetes  | Euro Endocrinology 2023 | Diabetes mellitus | Diabetes Treatment

Track-12: Diabetic Disorders and Treatment

Diabetes, constantly referred to by specialists as diabetes mellitus, depicts a gathering of diabetes and metabolic affections in which the existent has high blood (glucose), either in light of the fact that insulin generation is lacking or on the grounds that the body's phones do not reply meetly to insulin or both. Cases with high glucose will typically encounter polyuria ( nonstop pee), they will turn out to be precipitously parched (polydipsia) and empty (polyphagia). Feting type 1 and type 2 diabetes at determination is critical. Average rates of type 2 diabetes incorporate the Slow and guileful onset, most normal in fat or fat patients from a adolescence bunch ( Native Americans, blacks, and Pacific Islanders), Signs of insulin resistance, robust case history of kind a brace of diabetes. Domestic way of life peril factors egging heftiness might be available, as may a family history of cardiovascular complaint or metabolic complaint. Pediatric Diabetes is a type 1 diabetes mellitus that requires insulin treatment.

Diabetes Conference | Diabetes Conferences | Diabetes congress | Endocrinology Conference | Obesity Conference | Euro Endocrinology 2023 | Diabetes Conference 2023 | Diabetes Conferences | Diabetes congress 2023 | Endocrine Disorders | Diabetes Congress | Type1 Diabetes | Type2 Diabetes  | Euro Endocrinology 2023 | Diabetes mellitus | Diabetes Treatment

Track-13: Advanced Technologies for Treatment of Diabetes

The conception of 'new innovations' for type one diabetes and new revelation and propelled type 2 diabetes treatment has extended as currently at a rate that some ought to seriously think about just like 'Moore's Law', and therefore the sheer range of recent advancements going into the type one diabetes business centre is likewise developing at a surprising rate. From the patient's viewpoint, this is energizing as well as can prompt a feeling of positive thinking. Advancements that today are developing typical (e.g. insulin pumps, quick HbA1c perceptive, and so forth go under new remedial instruments of diabetes. Without a doubt, it might be contended that the $64000 advances in type one diabetes care made within the half-moon of a century have originated from innovation rather than science. In the in the meantime, not all new innovations succeed (e.g. the Glucowatch), paying very little relevance their silent guarantee. Both type 1 diabetes patients and their medicinal services suppliers will soon see a progression of further propelled therapeutic advancements utilized as a part of doctor's facility and new innovations and novel treatments in diabetes treatment whose premise is fixing to the idea of enhancing the lives of those with the malady.

Diabetes Conference | Diabetes Conferences | Diabetes congress | Endocrinology Conference | Obesity Conference | Euro Endocrinology 2023 | Diabetes Conference 2023 | Diabetes Conferences | Diabetes congress 2023 | Endocrine Disorders | Diabetes Congress | Type1 Diabetes | Type2 Diabetes  | Euro Endocrinology 2023 | Diabetes mellitus | Diabetes Treatment

Track-14: Case Reports and Others

Lipid disorders are a group of medical conditions that see inordinate situations of fatty substances within the blood. These fatty substances include cholesterol and triglycerides. An excess of bad cholesterol increases your threat of heart complaint and stroke. A paraganglioma is a rare neuroendocrine lump that may develop at various body spots ( including the head, neck, abdomen, and tummy). About 97 are benign and cured by surgical junking; the remaining 3 are malignant lump because they're capable to produce distant metastases."Paraganglioma"is presently the most extensively accepted term for these lesions that are jointly delineated as glomus lump, chemodectoma, perithelioma, fibroangioma, and natural nevi. Metabolic diseases of bone strength, are generally caused by abnormalities of minerals ( similar as Ca or phosphorus (P)), vitamin D, bone mass, or bone structure. The most common metabolic bone complaint is osteoporosis.

Diabetes Conference | Diabetes Conferences | Diabetes congress | Endocrinology Conference | Obesity Conference | Euro Endocrinology 2023 | Diabetes Conference 2023 | Diabetes Conferences | Diabetes congress 2023 | Endocrine Disorders | Diabetes Congress | Type1 Diabetes | Type2 Diabetes  | Euro Endocrinology 2023 | Diabetes mellitus | Diabetes Treatment

Importance & Scope:

In 2012 there were 1.5 million deaths worldwide directly caused by diabetes. It was the eighth leading cause of death among both sexes and the fifth leading cause of death in women in 2012. Blood glucose levels that are higher than optimal, even if below the diagnostic threshold for diabetes, are a major source of mortality and morbidity. The diagnostic criterion for diabetes is fasting plasma glucose ≥ 7.0 mmol/L – a diagnostic point selected on the basis of microvascular complications such as diabetic retinopathy. The risk of macro-vascular diseases, such as heart attack or stroke, however, starts increasing well before this diagnostic point. To better understand the full impact of blood glucose levels on mortality, therefore, requires a look at mortality related to blood glucose as a risk factor. The total burden of deaths from high blood glucose1 in 2012 has been estimated to amount to 3.7 million. This number includes 1.5 million diabetes deaths, and an additional 2.2 million deaths from cardiovascular diseases, chronic kidney disease, and tuberculosis related to higher-than-optimal blood glucose. Its magnitude highlights that high blood glucose causes a large burden of mortality beyond those deaths directly caused by diabetes. The largest number of deaths resulting from high blood glucose occurs in upper-middle-income countries (1.5 million) and the lowest number in low-income countries (0.3 million). After the age of 50, middle-income countries have the highest proportion of deaths attributed to high blood glucose, for both men and women.

Except in high-income countries, the proportion of deaths attributable to high blood glucose for both men and women are highest in the age group 60–69 years. Forty-three percent of all deaths attributable to high blood glucose occur prematurely, before the age of 70 years – an estimated 1.6 million deaths worldwide. Globally, high blood glucose causes about 7% of deaths among men aged 20–69 and 8% among women aged 20–69.

The endocrine system is a network of glands that produce and release hormones that help control many important body functions, including the body's ability to change calories into energy that powers cells and organs. The endocrine system influences how your heart beats, how your bones and tissues grow, even your ability to make a baby. It plays a vital role in whether or not you develop diabetes, thyroid disease, growth disorders, sexual dysfunction, and a host of other hormone-related disorders.

High blood glucose kills about 3.4 million people worldwide, annually. More than 80% of these deaths occur in low- and middle-income countries, and almost half are people aged less than 70 years. Diabetes deaths will be doubled between 2005 and 2030, as per WHO projections.

The prevalence of endocrine disorders is increasing among all ages in Europe, mostly due to increases in overweight and obesity, unhealthy diet and physical inactivity. About 60 million people with diabetes in the European Region and about 10.3% of men and 9.6% of women aged 25 years and over.

The incidence and prevalence of diabetes has been increasing in countries throughout the world. This situation is clearly reflected in the recently published data from the NCD-RisC (Non-Communicable Diseases Risk Factors Collaboration) study, showing that the number of individuals with diabetes quadrupled between 1980 and 2014, particularly in developing countries. United Kingdom has not escaped this upward trend. The Diabetes study reported an age- and sex-adjusted total prevalence of 13.8%, and almost half the affected individuals (6%) were unaware of their condition. Furthermore, the expectations for the future are not reassuring: The International Diabetes Federation has estimated that this disease will affect 642 million adults aged 18 to 79 years in 2040 (this same organization established the value at 415 million in 2015), and approximately 90% of them will have diabetes type. Since 7% to 14% of their current budget is allocated to the treatment of this disease. Recent studies in Europe4 have shown that patients with diabetes consume twice the amount of health care resources as the nondiabetic population, and the cost increases as patients develop chronic complications. There are several reasons for the rise in the incidence and prevalence of this condition, such as increases in the dual epidemic of excess weight and obesity5 and in sedentary lifestyles, as well as population aging.

One key factor related to the higher prevalence is the improvement in survival prompted by various therapies that enable better glycemic control, and especially, control of cholesterol levels and hypertension. Diabetes is associated with considerable morbidity and mortality, mainly of cardiovascular origin. More than 75% of hospitalizations and more than 50% of deaths in this population are due to cardiovascular causes, as has been extensively reported. The Steno-2 study showed that intensive, multifactorial management of hyperglycemia, hypercholesterolemia, and hypertension, together with antiplatelet therapy, result in effective reductions in vascular complications and mortality in the type 2 diabetes population, with decreases of 57% in cardiovascular deaths and 46% in overall mortality. In a recent update of that study, intensive treatment during the first 7 or 8 years was associated with a mean increase in life expectancy of 7.9 years after a follow-up period of 21 years.6

Member Associated with Diabetes and Endocrinology Research:

To support, instruct, redesign and prepare enrolled restorative experts, dieticians, qualified medical caretakers and other properly qualified paramedical staff in the field of Diabetes different surely understood social orders/affiliations are working over the globe to effectively avert and battle the deadly infection.

The European Society of Endocrinology (ESE) is a logical society to advance for people in general advantage exploration, instruction and clinical practice in endocrinology by the association of meetings, instructional classes and productions, by raising open mindfulness, contact with national and worldwide officials.

Market value on Diabetic Research:

This measurement shows the main ten pharmaceutical organizations in view of worldwide hostile to diabetic income in 2014 and a projection for 2020, in million U.S. dollars. In 2014, Merck and Co created around six billion U.S. dollars in against diabetic income and is required to create more than eight billion U.S. dollars by 2020. Hostile to diabetic prescription is regularly ingested orally, except for insulin, exenatide, liraglutide, and pramlintide. Drugs used to treat diabetes mellitus are frequently called oral hypoglycemic specialists or oral antihyperglycemic operators.

No.Of Diabetic Effected Persons (Prevalence rate)

Major Associations of Endocrinology and Diabetes around the Globe

• Endocrine Society
• American Association of Clinical Endocrinologists
• The American Association of Endocrine Surgeons
• Association of Program Directors in Endocrinology, Diabetes and Metabolism
• Society for Endocrinology
• Brazilian Society of Surgical Endocrinology
• British Society for Paediatric Endocrinology and Diabetes
• European Society of Endocrinology
• International Society of Endocrinology
• Paediatric Endocrine Society

Key players in Endocrinology and Diabetes

• Associations of Endocrinology in USA
• American Association of Clinical Endocrinologists
• Association of Program Directors in Endocrinology & Metabolism (APDEM)
• Endocrine Fellows Foundation
• Society for Endocrinology
• The Endocrine Society
• Union Endocrinology Associates
• American Association of Endocrine Surgeon
• American Thyroid Association
• National Institute of Diabetes and Digestive and Kidney Diseases
• Centres for Disease Control: Division of Diabetes Translation

The top universities having the Endocrinology and Diabetes department:

• Harvard University
• University of Oxford
• University of Cambridge
• Johns Hopkins University
• Stanford University
• Yale University
• University of California, Los Angeles (UCLA)
• Imperial College London
• University of Melbourne
• Karolinska Institute

Societies Associated with Endocrinology and Diabetes Research

• European Biological Rhythms Society    
• European Calcified Tissue Society
• European Network for the Study of Adrenal Tumours   
• European Neuroendocrine Association   
• European Neuroendocrine Tumour Society
• European Society for Paediatric Endocrinology 
• European Society of Gynaecology
• German Endocrine society
• Diabetes UK
• The European Society of Endocrinology
• International Society of Endocrinology
• Spanish Society of Endocrinology
• The Society of Endocrinology
• The Endocrine Society of India

Hospitals for endocrinology and diabetes care

Mayo Clinic | Cleveland Clinic | Massachusetts General Hospital | Johns Hopkins Hospital | UCSF Medical Center | New York-Presbyterian University Hospital of Columbia and Cornell | Yale-New Haven Hospital | Northwestern Memorial Hospital | UCLA Medical Center |Hospitals of the University of Pennsylvania-Penn Presbyterian | Brigham and Women’s Hospital | Florida Hospital Orlando | cedars-Sinai Medical Center | Barnes-Jewish Hospital | Beaumont Hospital | Mount Sinai Hospital | Froedtert Hospital and the Medical College of Wisconsin | Lancaster General Hospital | University of Kansas Hospital | Abbott Northwestern Hospital | Advocate Sherman Hospital | Ascension Providence Hospital-Southfield | Avera McKennan Hospital and University Health Center | Barnes-Jewish Hospital | Beaumont Hospital-Grosse Pointe | Beaumont Hospital-Royal Oak | Beaumont Hospital-Troy | Carilion Roanoke Memorial Hospital | Christ Hospital | Cleveland Clinic Fairview Hospital | Deaconess Hospital | DMC Harper University Hospital | Duke University Hospital | Edward Hospital | El Camino Hospital | Elmhurst Hospital | Emory Saint Joseph's Hospital | Emory University Hospital | Englewood Hospital McLaren Flint Hospital | McLaren Macomb Hospital | Memorial Hermann Greater Heights Hospital | Mercy Hospital St. Louis | Methodist Hospital-San Antonio | Mount Sinai Beth Israel Hospital | Mount Sinai Hospital | Mount Sinai West and Mount Sinai St. Luke's Hospitals | New York-Presbyterian Hospital-Columbia and Cornell | New York-Presbyterian Queens Hospital | NewYork-Presbyterian Brooklyn Methodist Hospital Xinqiao Hospital Third Military Medical University  Kyoto University Hospital | Koo Foundation Sun Yat Sen Cancer Center | Taichung Veterans General Hospital | Riyadh Military Hospital | Beijing Maternity Hospital | Sun Yat-sen University First Affiliated Hospital | Chung Ho Memorial Hospital Kaohsiung Medical University | National Center of Neurology and Psychiatry | Queen Sirikit National Institute of Child Health | Cheng Ching Hospital | Seoul National University Hospital | Tianjin Medical University Hospital | Shin Kong Wu Ho Su Memorial Hospital | Beijing Tong Ren Hospital Capital Medical University | Dokkyo Medical University Hospital | Taipei City Hospital | Guangdong Provincial People's Hospital | Heping Hospital of Changzhi Medical College | Singapore National University Hospital | Armed Police General Hospital | Cathay General Hospital | Zhongshan Hospital Fudan University | Asan Medical Center Seoul

Companies for endocrinology and diabetes care:

Eli Lilly and Co | Bayer AG | AbbVie Inc | Sanofi | GlaxoSmithKline Plc | Johnson & Johnson  | Merck & Co Inc | F. Hoffmann-La Roche Ltd|Novartis | Pfizer Inc | Becton | Dickinson and Company  | Eli Lilly and Company  | Johnson & Johnson  | Medtronic, Inc. | Novo Nordisk | Regeneron Pharmaceuticals Inc. | Sanofi  | DexCom Inc.  | Insulet Corporation  | Myriad Genetics  | Lexicon Pharmaceuticals Inc.  | MannKind Corporation  | Tandem Diabetes Care Inc.  | Victoza, Levemir | Humalog | NovoLog | Invokana | Humulin | Trulicity | Onglyza | Teva Pharmaceutical Industries | Takeda Pharmaceutical | Sanofi | Novon Nordisk | Regeneron Pharmaceuticals | Bristol-Myers Squibb | Novartis | Lexicon Pharmaceuticals | ManKind Corporation | Tandem Diabetes Care | Abbott Laboratories | Eli Lilly & Co, Levemir | Roche | GlaxoSmithKline | Fidia Farmaceutici | ACS DOBFAR | Angelini | Pfizer | Recordati | Apharm | Dipharma | CellPly | Newron Pharmaceuticals | Zambon | Charles River Laboratories | Procus | AbbVie | Adienne Pharma and Biotech | CordenPharma | VitalMED | Diatheva | Silicon Biosystems | Flamma | Pediatric diabetes | Menarini | Patheon | SI-BONE | Bayer | Baxter | DiaSorin | Syneos Health | BioAlps | Endo Pharmaceuticals Inc | DiaSorin | Nexus BioPharma Inc | MDedge Endocrinology | AbbVie | Bayer | Roche | Novartis | Sanofi | GlaxoSmithKline | Teva Pharmaceutical Industries | AstraZeneca | Boehringer Ingelheim | Bristol-Myers Squibb | Merck KGaA and Bristol-Myers Squibb | Boehringer Ingelheim and Eli Lilly | Novartis | AstraZeneca | Kyoza Hakko Kirin | Merck & Co | Martindale Pharma | Novartis | Novo Nordisk A/S | Octapharma AG | Petrone Group | Pur UCB -pharma Alexion | AstraZeneca | Baxter | Bayer Ag | Boehringer Ingelheim | Chemnovatic | CSL Behring | Custom Pharmaceuticals | Eli Lilly | Fujirebio Europe | Galen Limited | GlaxoSmithKline na Pharmaceuticals | Roche | Sanofi | Pasteur SA | Servier | Shire | Uni-Pharma

DISCLAIMER
The information developed in this report is intended only for the purpose of understanding the scope of hosting related international meetings at the respective locations. This information does not constitute managerial, legal or accounting advice, nor should it be considered as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is speculative in nature. Conference Organizers take no responsibility for any loss or damage that might result from reliance on the reported information or from its use.